Skip to content
Dosage GuideResearch Reference

5-Amino-1MQ Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for 5-Amino-1MQ. All information is for educational purposes only.

Quick Answer

Typical oral doses of 5-Amino-1MQ range from 50-100 mg, taken one to two times daily. Some users experiment with higher doses up to 150 mg once daily, although supporting data is limited. It can be taken with or without food. Subcutaneous injection is primarily used in research; oral bioavailability is reasonable.

→ 5-Amino-1MQ Benefits→ 5-Amino-1MQ Side Effects→ Full 5-Amino-1MQ Profile
Table of Contents

Standard Dosage Range

Research dosing range: 50–100 mg per dose (oral)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Metabolic Rate Optimization

50 mg1–2× daily
Duration

8–12 weeks

Start with a lower dose to assess tolerance. Monitor for any adverse effects like gastrointestinal discomfort or headache.

White-to-Beige Fat Conversion

100 mg1× daily
Duration

8–12 weeks

Higher dose used by some researchers; monitor closely. May be more effective when combined with exercise and a healthy diet.

Diet-Resistant Obesity (preclinical research)

Variable (mg/kg in animal models)Daily
Duration

Variable (study-dependent)

Human equivalent not established. Oral dosing preferred; subcutaneous injection is unnecessary for most users.

Timing & Frequency

5-Amino-1MQ can be taken at any time of day, with or without food. Some users prefer to take it in the morning to potentially boost metabolic rate throughout the day. Consistent daily timing is generally recommended.

Cycle Guidance

Given the lack of long-term human safety data, cycling is advised. A common approach is 8-12 weeks on, followed by 4-8 weeks off. This is primarily precautionary. Monitor for any unexpected effects. Discontinue use immediately if adverse effects occur.

Reconstitution Reference

Quick reference for reconstituting 5-Amino-1MQ. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeN/A (oral capsules)
BAC Water VolumeN/A
Concentration & DrawN/A
StorageStore capsules at room temperature, away from direct sunlight and moisture.
StabilityFollow manufacturer’s expiration date on product packaging.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the recommended 5-Amino-1MQ dosage for fat loss?
Typical oral doses are between 50-100 mg per day, taken in one or two divided doses. Some users experiment with up to 150 mg once daily. Start with a lower dose (50 mg) to assess tolerance before increasing. Doses above 100 mg have limited supporting data and are not clinically validated.
Should I take 5-Amino-1MQ with or without food?
5-Amino-1MQ can be taken with or without food, according to most protocols in the research community. Some users find that taking it with food reduces the likelihood of mild gastrointestinal discomfort. Experiment to find what works best for you.
How long does it take to see results from 5-Amino-1MQ?
Anecdotal reports suggest that noticeable effects on energy levels and body composition may occur within 4-8 weeks of consistent use. However, individual responses will vary. Because there is no human clinical data, results are highly variable. Adhere to the suggested 8-12 week cycle before assessing.
Is subcutaneous injection necessary for 5-Amino-1MQ?
No. Subcutaneous injection is used in preclinical animal studies to ensure accurate dosing. Oral bioavailability is reasonable for this small molecule. Therefore, subcutaneous injection is not necessary or recommended for most users.
What should I do if I experience side effects?
If you experience any side effects while taking 5-Amino-1MQ, reduce your dose or discontinue use. Common side effects are mild nausea and headache. Immediately discontinue use and consult a medical professional if serious effects occur.

References

  1. 1
    NNMT inhibition effectively activates NAD+ salvage pathway in adipocytes and prevents diet-induced obesity(2020)PubMed ↗
  2. 2
    Small molecule NNMT inhibitors for the treatment of obesity and metabolic syndrome(2021)PubMed ↗
  3. 3
    Discovery of selective inhibitors of human nicotinamide N-methyltransferase(2013)PubMed ↗

Last updated: 2026-02-19